In very rare cases, patients taking Temodal and medicines like it may have a small risk of developing secondary cancers, including leukaemia.
Meget sjældent kan patienter, som tager Temodal eller lignende medicin, have en lille risiko for at udvikle en sekundær kræftform, inklusiv leukæmi.